Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release 2008 second quarter financial results prior to market open on Tuesday, July 29, 2008. Company management will host an investment-community conference call beginning at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time) on Tuesday, April 29 to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing (888) 803-8271 for domestic callers, or (706) 634-2467 for international callers, or from the webcast on the investor relations section of the Company’s Web site at www.spectranetics.com.
A 48-hour telephone replay will be available approximately one hour after the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers, and entering reservation code 56798251. The webcast will be available on the Company’s Web site for 14 days following the completion of the call.
About Spectranetics
Founded in 1984, Spectranetics manufactures and sells the only excimer laser approved in the United States, Europe and Japan for use in minimally invasive cardiovascular procedures. This technology treats complex cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream. The Company’s disposable catheters use high-energy “cool” ultraviolet light to vaporize arterial blockages in the legs and heart, as well as scar tissue encapsulating pacing and defibrillation leads. For more information, visit www.spectranetics.com.
Contacts:
John Schulte, Chief Executive Officer
Guy
Childs, Chief Financial Officer
(719) 633-8333
or
Investor
& Media Contacts:
Lippert/Heilshorn &
Associates, Inc.
Don Markley or Bruce Voss
dmarkley@lhai.com
(310)
691-7100
